Effect of a Cross-Training and Resistance Exercise Routine on IL-15 in Adults with Type B Acute Lymphoblastic Leukemia during the Induction Phase : Randomized Pilot Study
IL-15 is a proinflammatory myokine essential for activating NK cells and CD8+ T lymphocytes, and its overexpression has been related to reducing overall survivorship in patients with acute lymphoblastic leukemia (ALL). Physical exercise has been shown to be safe, feasible, and beneficial in hematological cancers. Exercise requires the activation of muscles that secrete cytokines, such as IL-15, causing immune mobilization. The objective was to compare the outcomes of two training routines on IL-15 and survival prognosis in adult patients diagnosed with ALL. A blind randomized clinical study was carried out where twenty-three peripheral blood samples were obtained pre and postexercise intervention from patients categorized into three types of intervention: the resistance exercise group (REG), the cross-training exercise group (CEG), and the control group (CG). Changes in IL-15 levels during the intervention were not significant in any of the groups (CG p = 0.237, REG p = 0.866, and CEG p = 0.678). However, 87.5% of patients who received an exercise intervention achieved remission, while only 21.73% experienced a relapse. There were no deaths during the study. Although IL-15 level adaptation in the REG and the CG performed similarly, the REG induced a better clinical outcome. Resistance exercises may help improve survival prognosis and reduce relapses in patients with ALL.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Journal of functional morphology and kinesiology - 9(2023), 1 vom: 21. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gallardo Rodríguez, Adán Germán [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute lymphoblastic leukemia |
---|
Anmerkungen: |
Date Revised 29.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jfmk9010004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370249682 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370249682 | ||
003 | DE-627 | ||
005 | 20240330001717.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240328s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jfmk9010004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1355.xml |
035 | |a (DE-627)NLM370249682 | ||
035 | |a (NLM)38535413 | ||
035 | |a (PII)4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gallardo Rodríguez, Adán Germán |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of a Cross-Training and Resistance Exercise Routine on IL-15 in Adults with Type B Acute Lymphoblastic Leukemia during the Induction Phase |b Randomized Pilot Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a IL-15 is a proinflammatory myokine essential for activating NK cells and CD8+ T lymphocytes, and its overexpression has been related to reducing overall survivorship in patients with acute lymphoblastic leukemia (ALL). Physical exercise has been shown to be safe, feasible, and beneficial in hematological cancers. Exercise requires the activation of muscles that secrete cytokines, such as IL-15, causing immune mobilization. The objective was to compare the outcomes of two training routines on IL-15 and survival prognosis in adult patients diagnosed with ALL. A blind randomized clinical study was carried out where twenty-three peripheral blood samples were obtained pre and postexercise intervention from patients categorized into three types of intervention: the resistance exercise group (REG), the cross-training exercise group (CEG), and the control group (CG). Changes in IL-15 levels during the intervention were not significant in any of the groups (CG p = 0.237, REG p = 0.866, and CEG p = 0.678). However, 87.5% of patients who received an exercise intervention achieved remission, while only 21.73% experienced a relapse. There were no deaths during the study. Although IL-15 level adaptation in the REG and the CG performed similarly, the REG induced a better clinical outcome. Resistance exercises may help improve survival prognosis and reduce relapses in patients with ALL | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Interleukin-15 | |
650 | 4 | |a acute lymphoblastic leukemia | |
650 | 4 | |a body composition | |
650 | 4 | |a chemotherapy | |
650 | 4 | |a exercise | |
700 | 1 | |a Olarte Carrillo, Irma |e verfasserin |4 aut | |
700 | 1 | |a Martínez Tovar, Adolfo |e verfasserin |4 aut | |
700 | 1 | |a Cerón Maldonado, Rafael |e verfasserin |4 aut | |
700 | 1 | |a Martínez Moreno, Emmanuel |e verfasserin |4 aut | |
700 | 1 | |a Ramos Peñafiel, Christian Omar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of functional morphology and kinesiology |d 2017 |g 9(2023), 1 vom: 21. Dez. |w (DE-627)NLM279403852 |x 2411-5142 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2023 |g number:1 |g day:21 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jfmk9010004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2023 |e 1 |b 21 |c 12 |